Members Quarterly desk CNEUUS June 30, 2026

2026 Q2 desk: SCCS season, China methods, MoCRA status board

Owner takeaway

1. SCCS opinions ≠ annex law.
2. China method announcements (No. 51 and friends) are lab work.
3. Mercury STSC date 1 July 2026 was the China cliff at quarter-end.
4. FDA Voices is a status board; listing is still the live US duty.
5. Do not start EU allergen artwork in Q3 if Q2 did not freeze the fragrance files.

Why this now

Close of 2026 Q2.

Who is affected

Owners who want one page, not twelve tabs.

What to do

Monitor

SCCS list; NMPA 公告通告; FDA MoCRA page.

Prepare

Allergen artwork and mercury specs before July.

Act

Anything still unplaced in the EU on old allergen art is now a Q3 incident.

Analysis

Quarterly desk notes exist so we do not rewrite “what is EU regulation” every month. These five were the Q2 pile.

Unlock full analysis

Owner takeaway stays free. Choose a plan on the membership page to read the full decision memo comfortably — paid plans also include Workbench and Verify credits.

Sources & related

Linked news

Track updates in Workbench, or upgrade for full Regulatory Details and follow-up tools.

Always confirm against official sources before decisions.

Scroll to Top